Cargando…
Systematic identification of non-coding pharmacogenomic landscape in cancer
Emerging evidence has shown long non-coding RNAs (lncRNAs) play important roles in cancer drug response. Here we report a lncRNA pharmacogenomic landscape by integrating multi-dimensional genomic data of 1005 cancer cell lines and drug response data of 265 anti-cancer compounds. Using Elastic Net (E...
Autores principales: | Wang, Yue, Wang, Zehua, Xu, Jieni, Li, Jiang, Li, Song, Zhang, Min, Yang, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085336/ https://www.ncbi.nlm.nih.gov/pubmed/30093685 http://dx.doi.org/10.1038/s41467-018-05495-9 |
Ejemplares similares
-
A Landscape of Pharmacogenomic Interactions in Cancer
por: Iorio, Francesco, et al.
Publicado: (2016) -
Structural variation of the coding and non-coding human pharmacogenome
por: Tremmel, Roman, et al.
Publicado: (2023) -
The genetic and pharmacogenomic landscape of snoRNAs in human cancer
por: Liu, Yaoming, et al.
Publicado: (2020) -
The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023) -
Pan-cancer analyses reveal the genetic and pharmacogenomic landscape of transient receptor potential channels
por: Pan, Tao, et al.
Publicado: (2022)